These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37609738)

  • 1. Prescribing practices of tranexamic acid for melasma: Delphi consensus from the Pigmentary Disorders Society.
    Sarkar R; Narayan R V; Vinay K; Lakhani R; Sinha S; Mysore V; Sendhil Kumaran M; Bhalla M; Das A; Swarnkar B; Mohan Thappa D; Podder I; Ojha Sharma R; Kumar Somani V; Barua S; Jagadeesan S; Dogra S
    Indian J Dermatol Venereol Leprol; 2023 [SEASON]; 90(1):41-45. PubMed ID: 37609738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomised, controlled, double-blind study of combination therapy of oral tranexamic acid and topical hydroquinone in the treatment of melasma.
    Shihab N; Prihartono J; Tovar-Garza A; Agustin T; Legiawati L; Pandya AG
    Australas J Dermatol; 2020 Aug; 61(3):237-242. PubMed ID: 32109318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of oral tranexamic acid, topical tranexamic acid, and modified Kligman's regimen in treatment of melasma.
    Sahu PJ; Singh AL; Kulkarni S; Madke B; Saoji V; Jawade S
    J Cosmet Dermatol; 2020 Jun; 19(6):1456-1462. PubMed ID: 32346962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, open-label, comparative study of oral tranexamic acid and tranexamic acid microinjections in patients with melasma.
    Khurana VK; Misri RR; Agarwal S; Thole AV; Kumar S; Anand T
    Indian J Dermatol Venereol Leprol; 2019; 85(1):39-43. PubMed ID: 30333359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The optimal dose of oral tranexamic acid in melasma: A network meta-analysis.
    Wang WJ; Wu TY; Tu YK; Kuo KL; Tsai CY; Chie WC
    Indian J Dermatol Venereol Leprol; 2023; 89(2):189-194. PubMed ID: 36332095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinico-epidemiological profile and long term follow up in melasma.
    Kumaran MS; Narayan R V; Kaushik A; Bishnoi A; Vinay K; Parsad D
    Dermatol Ther; 2021 Nov; 34(6):e15143. PubMed ID: 34549495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral tranexamic acid lightens refractory melasma.
    Tan AWM; Sen P; Chua SH; Goh BK
    Australas J Dermatol; 2017 Aug; 58(3):e105-e108. PubMed ID: 27173008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing Melasma Management With Topical Tranexamic Acid: An Expert Consensus.
    Desai S; Chan L; Handog E; Djojoseputro L; Lim J; Ling R; Nguyen H; Tam E; Tang J; Thng S; Tran H
    J Drugs Dermatol; 2023 Apr; 22(4):386-392. PubMed ID: 37026889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the therapeutic efficacy and safety of combined oral tranexamic acid and topical hydroquinone 4% treatment vs. topical hydroquinone 4% alone in melasma: a parallel-group, assessor- and analyst-blinded, randomized controlled trial with a short-term follow-up.
    Lajevardi V; Ghayoumi A; Abedini R; Hosseini H; Goodarzi A; Akbari Z; Hedayat K
    J Cosmet Dermatol; 2017 Jun; 16(2):235-242. PubMed ID: 27762489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, open-label study to compare two different dosing regimens of oral tranexamic acid in treatment of moderate to severe facial melasma.
    Bhattacharjee R; Hanumanthu V; Thakur V; Bishnoi A; Vinay K; Kumar A; Parsad D; Kumaran MS
    Arch Dermatol Res; 2023 Aug; 315(6):1831-1836. PubMed ID: 36757440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral tranexamic acid (TA) in the treatment of melasma: A retrospective analysis.
    Lee HC; Thng TG; Goh CL
    J Am Acad Dermatol; 2016 Aug; 75(2):385-92. PubMed ID: 27206758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the tolerance and efficacy of laser-assisted delivery of tranexamic acid, niacinamide, and kojic acid for melasma: A single center, prospective, split-face trial.
    Park SJ; Park JW; Seo SJ; Park KY
    Dermatol Ther; 2022 Mar; 35(3):e15287. PubMed ID: 34962047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral Tranexamic Acid for the Treatment of Melasma: A Review.
    Bala HR; Lee S; Wong C; Pandya AG; Rodrigues M
    Dermatol Surg; 2018 Jun; 44(6):814-825. PubMed ID: 29677015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histological changes in facial melasma after treatment with triple combination cream with or without oral tranexamic acid and/or microneedling: A randomised clinical trial.
    Cassiano DP; Espósito ACC; Hassun KM; Lima MMDA; Lima EVA; Miot LDB; Miot HA; Bagatin E
    Indian J Dermatol Venereol Leprol; 2022; 88(6):761-770. PubMed ID: 35389028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral tranexamic acid for the treatment of melasma.
    Karn D; Kc S; Amatya A; Razouria EA; Timalsina M
    Kathmandu Univ Med J (KUMJ); 2012; 10(40):40-3. PubMed ID: 23575051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tranexamic acid in melasma: A focused review on drug administration routes.
    Konisky H; Balazic E; Jaller JA; Khanna U; Kobets K
    J Cosmet Dermatol; 2023 Apr; 22(4):1197-1206. PubMed ID: 36606378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tranexamic Acid in the Treatment of Melasma: A Review of the Literature.
    Perper M; Eber AE; Fayne R; Verne SH; Magno RJ; Cervantes J; ALharbi M; ALOmair I; Alfuraih A; Nouri K
    Am J Clin Dermatol; 2017 Jun; 18(3):373-381. PubMed ID: 28283893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of Oral Tranexamic Acid with Topical 3% Tranexamic Acid versus Oral Tranexamic Acid with Topical 20% Azelaic Acid in the Treatment of Melasma.
    Malik F; Hanif MM; Mustafa G
    J Coll Physicians Surg Pak; 2019 Jun; 29(6):502-504. PubMed ID: 31133144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized, placebo-controlled, double-blind study of oral tranexamic acid in the treatment of moderate-to-severe melasma.
    Del Rosario E; Florez-Pollack S; Zapata L; Hernandez K; Tovar-Garza A; Rodrigues M; Hynan LS; Pandya AG
    J Am Acad Dermatol; 2018 Feb; 78(2):363-369. PubMed ID: 28987494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of oral tranexamic acid for vitiligo patients with melasma.
    Chiang PH; Lin YJ; Chiu YC; Chung WH; Ku CL; Ng CY
    Dermatol Ther; 2021 Sep; 34(5):e15047. PubMed ID: 34190390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.